Showing results (771-780 of 806) with videos related to

Sort By:
Pageof 81
Genes & Development|May 15, 2026
MYC serine 62 phosphorylation promotes its association with DNA double-strand breaks to facilitate repair and cell survival under genotoxic stressGabriel M Cohn, Colin J Daniel, Jennifer R Eng, et al.
Journal of Asthma and Allergy|March 2, 2026
Donidalorsen for Long-Term Prophylaxis of Hereditary Angioedema Attacks: Results from the OASISplus Open-Label Extension Cohort at Year 1William R Lumry, Raffi Tachdjian, Timothy Craig, et al.
Clinical and Translational Allergy|March 4, 2026
An International Delphi Study on Barriers to On-Demand Treatment of Hereditary Angioedema AttacksAleena Banerji, Emel Aygören-Pürsün, Noemi-Anna Bara, et al.
The New England Journal of Medicine|June 15, 2026
Lonvoguran Ziclumeran - In Vivo CRISPR Gene Editing in Hereditary AngioedemaDanny M Cohn, Padmalal Gurugama, Hilary J Longhurst, et al.
Open Forum Infectious Diseases|February 12, 2021
Validation of N95 Filtering Facepiece Respirator Decontamination Methods Available at a Large University HospitalKrista R Wigginton, Peter J Arts, Herek L Clack, et al.
The New England Journal of Medicine|January 31, 2024
CRISPR-Cas9 In Vivo Gene Editing of KLKB1 for Hereditary AngioedemaHilary J Longhurst, Karen Lindsay, Remy S Petersen, et al.
Clinical and Translational Allergy|November 18, 2025
Sebetralstat for On-Demand Treatment of Mucosal Hereditary Angioedema Attacks in KONFIDENT-SJonathan A Bernstein, Emel Aygören-Pürsün, Mauro Cancian, et al.
Lancet (London, England)|February 11, 2023
An investigational oral plasma kallikrein inhibitor for on-demand treatment of hereditary angioedema: a two-part, randomised, double-blind, placebo-controlled, crossover phase 2 trialEmel Aygören-Pürsün, Andrea Zanichelli, Danny M Cohn, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 5, 2026
Impact of Oral Sebetralstat on Anxiety Associated With Hereditary Angioedema AttacksTimothy Craig, Emel Aygören-Pürsün, Jonathan A Bernstein, et al.
Frontiers in Allergy|July 13, 2026
The Chronic Angioedema Registry: what the first 2 years since the implementation of the global registry have taught usThomas Buttgereit, Mathias Sulk, Jonathan A Bernstein, et al.
Pageof 81